Search
Returning search results with filters:
Remove filter for
Issue: Product safety
Remove filter for
Recall class: Type I
Remove filter for
Type: Recall
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 15 of 133 items.
APO-AMITRIPTYLINE 10mg: NDMA Impurity
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 48-month stability testing timepoint.
RecallHealth product recall | 2023-02-07
PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
Pharmascience Inc. is recalling one lot of pms-Hydromorphone, 2 mg tablets, (lot 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone. Products from the affected lot…
RecallHealth product recall | 2022-08-22
Leucovorin Calcium Injection: Out of Specification
The assay is out of specification in the affected lot(s).
RecallHealth product recall | 2022-05-13
APO-AMITRIPTYLINE 10mg: NDMA impurity
Affected lots exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 36-month stability testing timepoint.
RecallHealth product recall | 2022-01-26
ELAVIL 10mg: NDMA impurity
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 36-month stability testing timepoint.
RecallHealth product recall | 2022-01-26
Dotarem Injection: Product Sterility
Product sterility may be compromised in the affected lot due to the possibility of defects in the vial.
RecallHealth product recall | 2021-11-22
Sivem Pharmaceuticals Losartan HCT product recall (2021-10-13)
Sivem Pharmaceuticals Losartan HCT product recall (2021-10-13)
Starting date:
October 13, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:…
RecallHealth product recall | 2021-10-13
Pharmascience PMS-Losartan product recall (2021-10-13)
Pharmascience PMS-Losartan product recall (2021-10-13)
Starting date:
October 13, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I…
RecallHealth product recall | 2021-10-13
Auro Pharma Losartan product recall (2021-10-12)
Auro Pharma Losartan product recall (2021-10-12)
Starting date:
October 12, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of…
RecallHealth product recall | 2021-10-12
Riva-Risperidone (2021-10-07)
Riva-Risperidone (2021-10-07)
Starting date:
October 7, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health…
RecallHealth product recall | 2021-10-07
Novo-Gesic Forte (2021-10-06)
Novo-Gesic Forte (2021-10-06)
Starting date:
October 6, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health…
RecallHealth product recall | 2021-10-06
Auro Pharma Losartan product recall (2021-10-01)
Auro Pharma Losartan product recall (2021-10-01)
Starting date:
October 1, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of…
RecallHealth product recall | 2021-10-01
Mirvala 28 (2021-09-30)
Mirvala 28 (2021-09-30)
Starting date:
September 30, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada…
RecallHealth product recall | 2021-09-30
Glucagon (2021-09-25)
Glucagon (2021-09-25)
Starting date:
September 25, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada…
RecallHealth product recall | 2021-09-25
Sanis Health Losartan / Losartan-HCTZ Product Recall (2021-09-10)
Sanis Health Losartan / Losartan-HCTZ Product Recall (2021-09-10)
Starting date:
September 10, 2021
Posting date:
September 16, 2021
Type of communication:
Drug Recall…
RecallHealth product recall | 2021-09-16